Project Grant HT94252510900
Award Date 9/30/25
Completion Date 9/29/29
Dollars Obligated $2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Wauwatosa, WI 53226, USA
Similar Awards
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is focused on identifying diagnostic biomarkers related to the cerebrovascular contributions to cognitive impairment in repeated blast concussion. The $1,999,996.00 grant was awarded to Temple University on June 1, 2025, with a planned completion date of May 31, 2029. The research is expected to transform healthcare for military service members, veterans, and the...
- The Defense Health Agency awarded a $1,131,357 Project Grant titled "MicroRNA Biomarkers of Cumulative Blast-Mild Traumatic Brain Injury (Micro BCB)" under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research conducted by the Seattle Institute for Biomedical and Clinical Research, a non-profit institute, to investigate the use of microRNA biomarkers for detecting and monitoring the impact of mild traumatic brain injury related to blast...
- This federal Project Grant award of $1,314,065.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research on the dose-response relationship of acute traumatic brain injury (TBI) blood biomarkers with pathoanatomic neuroimaging findings. The project will be conducted by the University of California, San Francisco (UCSF) over a period of 3 years from September 1, 2025 to August 31, 2028. The research...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,699,157.00 to the University of Pittsburgh to evaluate the effectiveness of a traumatic brain injury whole blood test in improving assessment and triage for patients with mild traumatic brain injury presenting to civilian emergency departments. The project aims to generate data to support the clinical application of this diagnostic test, which...
- The U.S. Defense Health Agency has awarded a $1,395,898 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Medicortex Finland LTD for the project titled "POINT-OF-INJURY DIAGNOSIS OF TRAUMATIC BRAIN INJURY USING SALIVA". The 2-year grant, effective from June 15, 2024 to June 14, 2026, will fund research to develop a point-of-injury diagnostic tool for traumatic brain injury using saliva samples. This aligns with the program's objective of...
- The U.S. Defense Health Agency awarded a $616,150 Project Grant to The Johns Hopkins University to support the "BLAST-EXPOSURE OUTCOMES AND ASSOCIATED LONG-TERM SYMPTOM TRAJECTORIES RELATED TO ESSENTIAL RECOVERY-PATHWAYS (BOLSTER) BIOMARKER INITIATIVE" under the Military Medical Research and Development program (CFDA 12.420). The project aims to conduct advanced biomedical research to transform healthcare for military service members, veterans, and the broader public by developing...
- This $777,500 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting at the University of Wisconsin-Madison. The project aims to transform healthcare for military service members, veterans, and the broader public through advanced biomedical research. The 3-year project, commencing on June 1, 2025, will leverage the university's...
- The federal Project Grant award titled "FUNCTIONAL OUTCOMES AND BIOMARKERS IN OCCUPATIONAL BLAST EXPOSURE (FOB: OBE): THE IMPACT ON SERVICE MEMBERS, VETERANS, AND THEIR FAMILIES" is funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This $1,051,179 grant, awarded on September 15, 2025, supports research conducted by the Western Institute For Veterans Research (WIVR), a non-profit organization based in Salt Lake City, Utah. The...
- The U.S. Defense Health Agency awarded a $4,626,921 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period of August 1, 2025 to July 31, 2028, will fund research to elucidate the role of the neurovascular unit and related structural and functional neurological sequelae after exposure to repeated blast. This research aims to transform...
- The Defense Health Agency awarded a $3.755 million Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to investigate dual orexin antagonist treatment to prevent neurobehavioral sequelae of traumatic brain injury from April 1, 2023 to March 31, 2027. The Military Medical Research and Development program supports innovative medical research to improve warfighter health and transform public healthcare. Under this award,...